Málaga Capital
Málaga trials pioneering cell immunotherapy against melanoma and lung cancer
The Regional Hospital of Málaga and IBIMA offer TIL therapy for advanced melanoma and lung cancer, in trials since 2024.
IBIMA Plataforma BIONAND
Latest IBIMA Plataforma BIONAND news
3 articles
Málaga Capital
Málaga drives pioneering European research on SYNGAP1 syndrome
The University of Málaga participates in the EURAS project, seeking personalised treatments for SYNGAP1 syndrome through bioinformatics. It already includes 500 patients.
Málaga Capital
Málaga leads the trial of a personalised vaccine against melanoma
The Regional Hospital of Málaga contributes 24 of the 71 patients evaluated in Spain for a personalised mRNA vaccine trial against melanoma, with positive results.